Open Access

Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis

  • Authors:
    • Fengju Rong
    • Xue Gao
    • Kexin Liu
    • Jintao Wu
  • View Affiliations

  • Published online on: March 20, 2018     https://doi.org/10.3892/etm.2018.5973
  • Pages: 4191-4198
  • Copyright: © Rong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

It has been suggested that endoplasmic reticulum stress (ERS) may induce apoptosis following spinal cord injury (SCI). Methotrexate (MTX) has been used as a long‑term therapy regimen for rheumatoid arthritis. However, it is not clear whether MTX remediates SCI by inhibiting ERS. In the present study, to establish an in vitro ERS cell model, PC12 cells were pre‑incubated with triglycerides (TG). MTT assays revealed that treatment with 1, 2.5, 5 and 10 µM TG decreased PC12 cell viability in a dose‑dependent manner. Additionally, MTX treatment significantly reversed the TG‑induced decrease in cell viability and increased apoptosis according to the flow cytometry assay (P<0.05). Notably, western blotting indicated that MTX significantly decreased levels of glucose‑regulated protein (GRP)78, CCAAT‑enhancer‑binding protein homologous protein (CHOP) and caspase‑12 expression (P<0.05), which were increased following treatment with TG. Furthermore, the in vivo role of MTX in a rat model of SCI was evaluated. The motor behavioral function of rats was improved following treatment with MTX according to Basso, Beattie and Bresnahan scoring (P<0.05). Terminal deoxynucleotidyl-transferase-mediated dUTP nick end staining indicated that there were no apoptotic cells present in sham rats. In the SCI model group, apoptotic cells were observed at day 7; however, the number of apoptotic cells was reduced following an additional 7 days of MTX administration. Furthermore, levels of ERS‑associated proteins, including caspase‑3, activating transcription factor 6, serine/threonine‑protein kinase/endoribonuclease inositol‑requiring enzyme 1 α, eukaryotic initiation factor 2 α and GRP78, were significantly increased following SCI; however, administration of MTX for 7 days significantly reversed this effect (P<0.05, P<0.01 and P<0.001). Therefore, MTX may improve SCI by suppressing ERS‑induced apoptosis in vitro and in vivo.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Rong F, Gao X, Liu K and Wu J: Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis. Exp Ther Med 15: 4191-4198, 2018
APA
Rong, F., Gao, X., Liu, K., & Wu, J. (2018). Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis. Experimental and Therapeutic Medicine, 15, 4191-4198. https://doi.org/10.3892/etm.2018.5973
MLA
Rong, F., Gao, X., Liu, K., Wu, J."Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis". Experimental and Therapeutic Medicine 15.5 (2018): 4191-4198.
Chicago
Rong, F., Gao, X., Liu, K., Wu, J."Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis". Experimental and Therapeutic Medicine 15, no. 5 (2018): 4191-4198. https://doi.org/10.3892/etm.2018.5973